RELX: The Risk Segment Makes This Buy Less Risky

RELX has maintained consistent growth and EPS compounding despite trading at roughly 50% of its all-time-high P/E, reflecting perceived disruption in its legal and scientific, technical and medical (STM) segments. Those segments are described as opportunities, while its high-margin Risk business benefits from a 13-petabyte data moat supporting digital identity screening and fraud prevention.

Analysis

The key valuation question is whether the market is pricing permanent disintermediation or a slower transition in how RELX’s data is accessed. Generative AI can weaken the value of searchable legal and scientific content, but may increase demand for authoritative, permissioned datasets and embedded workflows. That creates a barbell: proprietary risk and identity data may be more defensible than content sold primarily for retrieval, while the risk business also carries privacy, data-rights, and model-governance exposure. The asserted data moat is not itself proof of pricing power; verify segment growth, retention, and evidence that AI products are additive rather than cannibalizing existing subscriptions.

Near term, a valuation rebound needs estimate stability or upward revisions, not just a low historical multiple. Over 1–3 months, monitor results and management commentary for segment-level organic growth, renewal trends, and AI-related product adoption. Over 6–18 months, the decisive test is whether RELX can preserve monetization as customers shift workflows toward AI. A plausible contrarian view is that the multiple discount overstates substitution risk; the counter is that a lower multiple may be rational if content becomes less differentiated or privacy constraints limit data reuse. No valuation, estimates, or price data are supplied, so the discount alone does not establish an attractive entry.

Key Decisions for Investors

• Keep RELX on a conditional long watchlist rather than chase the valuation narrative. Consider a staged position only after confirming segment-level organic growth and stable or improving estimates; the thesis is falsified by sustained deceleration, weaker renewals, or guidance cuts tied to AI substitution.
• At the next results and on any material AI product announcements, verify whether adoption expands paid usage and retention versus shifting customers away from existing products. Treat company claims about the data moat as unproven until supported by those metrics.
• Monitor privacy and data-rights regulation, litigation, and restrictions on dataset use as downside catalysts: these could impair the economics of risk and identity screening even if demand for fraud prevention remains strong.
• Avoid a peer short or options trade without current valuation, earnings revisions, and relative-performance data. If those confirm RELX is discounting disruption while operating indicators remain resilient, reassess a long RELX versus information-services peers; otherwise there may be no trade.